Patent · US Active

PCNA inhibitors

US12054447B2 · kind B2 · utility

0Cited by
8References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2022
Grant dateAug 6, 2024
Priority date—
Expiry dateSep 13, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein, inter alia, are compositions of PCNA modulators and methods for treating or preventing cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.